Potential of Oral Cavity Stem Cells for Bone Regeneration: A Scoping Review

• Published in: Cells (Basel, Switzerland) Vol. 12; no. 10; p. 1392
• Main Authors: Alarcón-Apablaza, Josefa, Prieto, Ruth, Rojas, Mariana, Fuentes, Ramón
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 15.05.2023; MDPI
• Subjects: Bone density; Bone grafts; Bone growth; Bone loss; Bone Regeneration; Bones; Care and treatment; Case reports; Clinical trials; Congenital defects; Craniofacial abnormalities; Defects; Dental pulp; Diagnosis; Inflammation; Ligaments; Maxillofacial; Mesenchymal Stem Cells; Morbidity; Oral cavity; Osteogenesis; Patient outcomes; Periodontal Ligament; Periosteum; Regeneration; Regenerative medicine; Review; Reviews; Stem Cells; stomatognathic system; Stromal cells; Teeth; Tissue engineering; Transplantation; Chile; stem cells; bone regeneration; tissue engineering; stomatognathic system
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12101392

Bone loss is a common problem that ranges from small defects to large defects after trauma, surgery, or congenital malformations. The oral cavity is a rich source of mesenchymal stromal cells (MSCs). Researchers have documented their isolation and studied their osteogenic potential. Therefore, the objective of this review was to analyze and compare the potential of MSCs from the oral cavity for use in bone regeneration. A scoping review was carried out following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The databases reviewed were PubMed, SCOPUS, Scientific Electronic Library Online (SciELO), and Web of Science. Studies using stem cells from the oral cavity to promote bone regeneration were included. A total of 726 studies were found, of which 27 were selected. The MSCs used to repair bone defects were (I) dental pulp stem cells of permanent teeth, (II) stem cells derived from inflamed dental pulp, (III) stem cells from exfoliated deciduous teeth, (IV) periodontal ligament stem cells, (V) cultured autogenous periosteal cells, (VI) buccal fat pad-derived cells, and (VII) autologous bone-derived mesenchymal stem cells. Stem cells associate with scaffolds to facilitate insertion into the bone defect and to enhance bone regeneration. The biological risk and morbidity of the MSC-grafted site were minimal. Successful bone formation after MSC grafting has been shown for small defects with stem cells from the periodontal ligament and dental pulp as well as larger defects with stem cells from the periosteum, bone, and buccal fat pad. Stem cells of maxillofacial origin are a promising alternative to treat small and large craniofacial bone defects; however, an additional scaffold complement is required for stem cell delivery.